The firm hopes that its collaboration with Don't Forget Morgan will spur drug development for beta-propeller protein-associated neurodegeneration, a rare pediatric disease.
Ann Arbor, Michigan (PRWEB) February 22, 2022 Genomenon, Inc. recently announced a partnership with Don’t Forget Morgan, a nonprofit support organization